what are the pcsk9 inhibitors?
PCSK9 inhibitors are a new class of drugs that lower LDL, or “bad,” cholesterol. Right now, there are two FDA-approved medications: alirocumab (Praluent) and evolocumab (Repatha). Studies show that PCSK9 inhibitors have a powerful effect and in some cases can actually prevent heart attacks or strokes.